Views for No evidence for selection of HIV-1 with enhanced gag-protease or nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.
Total visits
| views | |
|---|---|
| No evidence for selection of HIV-1 with enhanced gag-protease or nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial. | 236 |
Total visits per month
| views | |
|---|---|
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
File Visits
| views | |
|---|---|
| Chopera_Denis_R_2013.pdf | 198 |
| Chopera_Denis_R_2013.pdf(legacy) | 31 |
Top country views
| views | |
|---|---|
| United States | 96 |
| South Africa | 49 |
| Germany | 18 |
| Sweden | 17 |
| Vietnam | 10 |
| Finland | 4 |
| Ireland | 4 |
| India | 4 |
| Netherlands | 4 |
| China | 3 |
| Russia | 3 |
| France | 2 |
| Moldova | 2 |
| Brazil | 1 |
| Canada | 1 |
| Italy | 1 |
| South Korea | 1 |
| Romania | 1 |
| Singapore | 1 |
Top city views
| views | |
|---|---|
| Ashburn | 50 |
| Johannesburg | 20 |
| Hanoi | 10 |
| Pretoria | 5 |
| Bengaluru | 4 |
| Dublin | 4 |
| Washington | 3 |
| Des Moines | 2 |
| Durban | 2 |
| New York | 2 |
| Paris | 2 |
| Santa Clara | 2 |
| Andover | 1 |
| Arezzo | 1 |
| Asan | 1 |
| Barueri | 1 |
| Bucharest | 1 |
| Chisinau | 1 |
| Heidelberg | 1 |
| Nanchang | 1 |
| Sandton | 1 |
| Seattle | 1 |
| Singapore | 1 |
| Stellenbosch | 1 |
| Tzaneen | 1 |
| Valencia | 1 |
| Villieria | 1 |
| West Palm Beach | 1 |